As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies. This was presented on 3rd Aptil 2020 to a global audience.
Register for part two of the series here.
SARS-CoV-2 Infected Host Cell Proteomics Reveal Potential Therapy Targets
Video Apr 06, 2020 | Taken from London Proteomics
Advertisement
Recommended Videos
Like what you just watched? You can find similar content on the communities below.
Analysis & Separations Cell Science Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Advertisement